US Drug Recall Register

FDA Drug Recalls

1,709 recalls · Class III, newest first

Class III · Low risk Terminated

risperiDONE ORALLY DISINTEGRATING TABLETS

Reason Failed Impurities/Degradation Specifications: Out of specification for a known degradant.

Zydus Pharmaceuticals USA Inc D-0725-2016
Class III · Low risk Terminated

NORepinephrine Bitartrate

Reason Subpotent Drug; confirmed results by FDA analysis after customer complaints of discoloration

Pharmedium Services, LLC NDC 61553-127-61 D-0778-2016
Class III · Low risk Terminated

NORepinephrine Bitartrate

Reason Subpotent Drug; confirmed results by FDA analysis after customer complaints of discoloration

Pharmedium Services, LLC NDC 61553-134-61 D-0777-2016
Class III · Low risk Terminated

Candesartan Cilexetil Tablets

Reason Failed Impurities/Degradation Specifications; 9 month stability timepoint

Sandoz Inc NDC 00781-5938-31 D-0659-2016
Class III · Low risk Terminated

Ranitidine Syrup

Reason Failed Impurities/Degradation Specifications: Product recalled due to elevated impurity result detected during routine stability testing.

Bio-pharm, Inc. NDC 23155-291-51 D-0809-2016
Class III · Low risk Terminated

Lindane Lotion

Reason Super-Potent Drug: Out of Specification Assay test results were reported for stability samples.

Morton Grove Pharmaceuticals, Inc. NDC 60432-833-60 D-0571-2016
Class III · Low risk Terminated

Lumizyme

Reason Labeling: Incorrect or Missing Lot and/or Exp Date

Genzyme Corporation NDC 58468-0160-1 D-0799-2016
Class III · Low risk Terminated

Quinapril Tablets USP 5 mg

Reason Failed Impurities/Degradation Specifications; Impurity A

Lupin Pharmaceuticals Inc. NDC 68180-556-09 D-0650-2017
Class III · Low risk Terminated

Norpace CR

Reason Failed Dissolution Specification

Pfizer Inc. NDC 0025-2742-31 D-0520-2016
Class III · Low risk Terminated

Meclizine Hydrochloride Tablets

Reason Failed Impurities/Degradation Specifications: Out of specification for impurities.

Golden State Medical Supply Inc. D-0510-2016
Class III · Low risk Terminated

Meclizine Hydrochloride Tablets

Reason Failed Impurities/Degradation Specifications: Out of specification for impurities.

Golden State Medical Supply Inc. D-0509-2016
Class III · Low risk Terminated

NABUMETONE Tablets USP

Reason Labeling: Not Elsewhere Classified: Lack of leaflets and approved labels on bottles.

Teva Pharmaceuticals USA D-0773-2016
Class III · Low risk Terminated

Prednisone 20 mg

Reason Labeling: Not elsewhere classified. NDC number is incorrect on the container.

Northwind Pharmaceuticals LLC NDC 51655-320-53 D-0485-2016
Class III · Low risk Terminated

Paricalcitol Capsules

Reason Failed Tablet/Capsule Specifications: Product recalled due to reports of breakage and leakage of Paricalcitol capsules.

Dr. Reddy's Laboratories, Inc. NDC 55111-665-30 D-0721-2016
Class III · Low risk Terminated

Paricalcitol Capsules

Reason Failed Tablet/Capsule Specifications: Product recalled due to reports of breakage and leakage of Paricalcitol capsules.

Dr. Reddy's Laboratories, Inc. NDC 55111-664-30 D-0720-2016
Class III · Low risk Terminated

Paricalcitol Capsules

Reason Failed Tablet/Capsule Specifications: Product recalled due to reports of breakage and leakage of Paricalcitol capsules.

Dr. Reddy's Laboratories, Inc. NDC 55111-663-30 D-0719-2016
Class III · Low risk Terminated

Meclizine Hydrochloride Tablets

Reason Failed Impurities/Degradation Specifications: Out of specification for impurities.

Mylan Institutional, Inc. (d.b.a. UDL Laboratories) D-0235-2016
Class III · Low risk Terminated

Magnesium Sulfate 7-Hydrate

Reason Failed Impurities/Degradation Specifications: Out of specifications results for impurities.

Avantor Performance Materials Inc D-0563-2016
Class III · Low risk Terminated

Epsom Salt

Reason Failed Impurities/Degradation Specifications: Level of iron exceeds the limit set by the USP monograph for it (USP limit is NMT 0.5 ug/g (ppm)).

PQ Corporation D-0564-2016
Class III · Low risk Terminated

Meclizine Hydrochloride Tablets USP

Reason Failed Impurities/Degradation Specifications: Out of specification for impurities.

Par Pharmaceutical Inc. D-0234-2016
Class III · Low risk Terminated

Meclizine Hydrochloride Tablets

Reason Failed Impurities/Degradation Specifications: Out of specification for impurities.

Par Pharmaceutical Inc. D-0233-2016
Class III · Low risk Terminated

Duloxetine Delayed-release Capsules

Reason Presence of Foreign Tablets/Capsules: one foreign capsule identified as omeprazole 10 mg was found in the bottle

Breckenridge Pharmaceutical, Inc D-0181-2016
Class III · Low risk Terminated

Ranitidine Syrup

Reason Failed Stability Specifications: Out of Specification results obtained for preservative butylparaben.

Vintage Pharmaceuticals LLC, DBA Qualitest Pharmaceuticals D-0162-2016